These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

221 related articles for article (PubMed ID: 31257672)

  • 1. High-salt diet promotes crystal deposition through hypertension in Dahl salt-sensitive rat model.
    Nakazawa Y; Inoue S; Nakamura Y; Iida Y; Ishigaki Y; Miyazawa K
    Int J Urol; 2019 Aug; 26(8):839-846. PubMed ID: 31257672
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of mineralocorticoid receptor blockade on the renal renin-angiotensin system in Dahl salt-sensitive hypertensive rats.
    Zhu A; Yoneda T; Demura M; Karashima S; Usukura M; Yamagishi M; Takeda Y
    J Hypertens; 2009 Apr; 27(4):800-5. PubMed ID: 19516179
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Renal arteriolar injury by salt intake contributes to salt memory for the development of hypertension.
    Oguchi H; Sasamura H; Shinoda K; Morita S; Kono H; Nakagawa K; Ishiguro K; Hayashi K; Nakamura M; Azegami T; Oya M; Itoh H
    Hypertension; 2014 Oct; 64(4):784-91. PubMed ID: 24980670
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mineralocorticoid receptor activation contributes to salt-induced hypertension and renal injury in prepubertal Dahl salt-sensitive rats.
    Kawarazaki H; Ando K; Nagae A; Fujita M; Matsui H; Fujita T
    Nephrol Dial Transplant; 2010 Sep; 25(9):2879-89. PubMed ID: 20466668
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CS-3150, a novel non-steroidal mineralocorticoid receptor antagonist, prevents hypertension and cardiorenal injury in Dahl salt-sensitive hypertensive rats.
    Arai K; Tsuruoka H; Homma T
    Eur J Pharmacol; 2015 Dec; 769():266-73. PubMed ID: 26607463
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of enalapril, tempol, and eplerenone on salt-induced hypertension in dahl salt-sensitive rats.
    Bayorh MA; Mann G; Walton M; Eatman D
    Clin Exp Hypertens; 2006 Feb; 28(2):121-32. PubMed ID: 16546838
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Role of central nervous system aldosterone synthase and mineralocorticoid receptors in salt-induced hypertension in Dahl salt-sensitive rats.
    Huang BS; White RA; Jeng AY; Leenen FH
    Am J Physiol Regul Integr Comp Physiol; 2009 Apr; 296(4):R994-R1000. PubMed ID: 19118098
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Chronic antagonism of the mineralocorticoid receptor ameliorates hypertension and end organ damage in a rodent model of salt-sensitive hypertension.
    Zhou X; Crook MF; Sharif-Rodriguez W; Zhu Y; Ruben Z; Pan Y; Urosevic-Price O; Wang L; Flattery AM; Forrest G; Szeto D; Zhao H; Roy S; Forrest MJ
    Clin Exp Hypertens; 2011; 33(8):538-47. PubMed ID: 21950654
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Aberrant ENaC activation in Dahl salt-sensitive rats.
    Kakizoe Y; Kitamura K; Ko T; Wakida N; Maekawa A; Miyoshi T; Shiraishi N; Adachi M; Zhang Z; Masilamani S; Tomita K
    J Hypertens; 2009 Aug; 27(8):1679-89. PubMed ID: 19458538
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Blood pressure, magnesium and other mineral balance in two rat models of salt-sensitive, induced hypertension: effects of a non-peptide angiotensin II receptor type 1 antagonist.
    Rondón LJ; Marcano E; Rodríguez F; del Castillo JR
    Magnes Res; 2014; 27(3):113-30. PubMed ID: 25560239
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prepubertal angiotensin blockade exerts long-term therapeutic effect through sustained ATRAP activation in salt-sensitive hypertensive rats.
    Dejima T; Tamura K; Wakui H; Maeda A; Ohsawa M; Kanaoka T; Haku S; Kengo A; Masuda S; Shigenaga A; Azuma K; Matsuda M; Yabana M; Hirose T; Uchino K; Kimura K; Nagashima Y; Umemura S
    J Hypertens; 2011 Oct; 29(10):1919-29. PubMed ID: 21844822
    [TBL] [Abstract][Full Text] [Related]  

  • 12. High salt intake and the brain renin--angiotensin system in Dahl salt-sensitive rats.
    Zhao X; White R; Huang BS; Van Huysse J; Leenen FH
    J Hypertens; 2001 Jan; 19(1):89-98. PubMed ID: 11204309
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mineralocorticoid receptor blockade and calcium channel blockade have different renoprotective effects on glomerular and interstitial injury in rats.
    Du J; Fan YY; Hitomi H; Kiyomoto H; Kimura S; Kong CZ; Noma T; Kohno M; Nishiyama A; Nakano D
    Am J Physiol Renal Physiol; 2009 Sep; 297(3):F802-8. PubMed ID: 19535572
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of aldosterone and angiotensin II receptor blockade on cardiac angiotensinogen and angiotensin-converting enzyme 2 expression in Dahl salt-sensitive hypertensive rats.
    Takeda Y; Zhu A; Yoneda T; Usukura M; Takata H; Yamagishi M
    Am J Hypertens; 2007 Oct; 20(10):1119-24. PubMed ID: 17903697
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Podocyte injury underlies the glomerulopathy of Dahl salt-hypertensive rats and is reversed by aldosterone blocker.
    Nagase M; Shibata S; Yoshida S; Nagase T; Gotoda T; Fujita T
    Hypertension; 2006 Jun; 47(6):1084-93. PubMed ID: 16636193
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Age-dependent salt hypertension in Dahl rats: fifty years of research.
    Zicha J; Dobešová Z; Vokurková M; Rauchová H; Hojná S; Kadlecová M; Behuliak M; Vaněčková I; Kuneš J
    Physiol Res; 2012; 61(Suppl 1):S35-S87. PubMed ID: 22827876
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of the novel nonsteroidal mineralocorticoid receptor blocker, esaxerenone (CS-3150), on blood pressure and urinary angiotensinogen in low-renin Dahl salt-sensitive hypertensive rats.
    Li L; Guan Y; Kobori H; Morishita A; Kobara H; Masaki T; Nakano D; Nishiyama A
    Hypertens Res; 2019 Jun; 42(6):769-778. PubMed ID: 30587856
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Eplerenone potentiates protective effects of amlodipine against cardiovascular injury in salt-sensitive hypertensive rats.
    Nakamura T; Fukuda M; Kataoka K; Nako H; Tokutomi Y; Dong YF; Yamamoto E; Yasuda O; Ogawa H; Kim-Mitsuyama S
    Hypertens Res; 2011 Jul; 34(7):817-24. PubMed ID: 21471977
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Aberrant Rac1-mineralocorticoid receptor pathways in salt-sensitive hypertension.
    Kawarazaki W; Fujita T
    Clin Exp Pharmacol Physiol; 2013 Dec; 40(12):929-36. PubMed ID: 24111570
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Renal functional, not morphological, abnormalities account for salt sensitivity in Dahl rats.
    Manger WM; Simchon S; Stokes MB; Reidy JJ; Kumar AR; Baer L; Gallo G; Haddy FJ
    J Hypertens; 2009 Mar; 27(3):587-98. PubMed ID: 19330919
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.